CGMs for Athletes in 2026: Signos, Levels & Ultrahuman Reviewed

Endurance athletes use CGMs to dial in fueling. Here is what the data actually shows.

CGMs for Athletes in 2026: Signos, Levels & Ultrahuman Reviewed

Continuous glucose monitors (CGMs) have crossed over from clinical diabetes management into endurance sports as athletes seek granular control over fueling, bonk prevention, and systemic recovery. While marketing suggests these wearable biosensors provide an unmediated window into cellular energy production, the underlying physiology of interstitial glucose dynamics creates both opportunities and distinct blind spots for athletic performance. Evaluating platforms like Levels, Signos, and Ultrahuman requires understanding the biological mechanisms of exercise-induced glucose shifts alongside the software analytics that interpret them.

Interstitial Fluid Kinetics and Exercise-Induced Hyperglycemia

A critical technical nuance often overlooked by athletes is that CGMs measure glucose concentrations within interstitial fluid, not capillary or venous blood. Glucose moves from capillaries into the interstitial space via passive diffusion, resulting in a physiological lag time typically ranging between 5 and 15 minutes at rest. During rapid shifts in cardiac output, peripheral vasodilation, and acute glycogen utilization, this lag can widen, meaning real-time CGM data displays what occurred minutes prior rather than instantaneous systemic availability.

Furthermore, exercise intensity dictates divergent glycemic responses that often confuse athletes unfamiliar with end-stage substrate oxidation. During low- to moderate-intensity aerobic exercise (Zones 1 and 2), muscle contractions stimulate the translocation of glucose transporter type 4 (GLUT4) proteins to the cell membrane independently of insulin, driving predictable, steady glucose clearance from circulation. In contrast, high-intensity intervals or threshold surges stimulate the sympathoadrenal axis, triggering a massive release of epinephrine and norepinephrine. This surge causes hepatic glycogenolysis to outpace peripheral uptake temporarily, producing acute glucose spikes exceeding 160 mg/dL in non-diabetic individuals without any exogenous carbohydrate intake. Software platforms that interpret these elevations as poor metabolic control fail to account for normal, adaptive neuroendocrine responses to vigorous exertion.

Hardware Ecosystems and Platform Features: Levels, Signos, and Ultrahuman

The consumer CGM market does not manufacture its own biosensors; instead, services overlay proprietary software, algorithmic interpretations, and coaching atop medical-grade sensors manufactured by Abbott (FreeStyle Libre family) or Dexcom (G7 and Stelo lines). These sensors boast mean absolute relative difference (MARD) scores between 8% and 9%, reflecting high analytical accuracy in steady-state clinical conditions, though physical compression or rapid sensor motion can cause transient mechanical artifacts.

Levels operates primarily as a metabolic lifestyle and training platform, offering integrations with Dexcom and Abbott hardware. The app emphasizes postprandial glucose excursions, macro tracking, and stability scoring, allowing athletes to log workouts via Apple Health, Garmin, or Wahoo to correlate glycemic curves with training strain. Pricing typically sits around $199 annually for platform access, with hardware bundles adding roughly $150 to $200 per month depending on sensor choice and shipment frequency.

Signos focuses on adaptive AI modeling, utilizing Dexcom sensors to predict glucose trajectories and recommend targeted activity bouts. For athletes, Signos emphasizes matching pre-workout carbohydrate ingestion to impending energy demands, attempting to flag when glycogen reserves or circulating glucose drop below a critical threshold. Subscriptions generally run from $159 to $299 per month based on the commitment term, positioning it higher on the cost spectrum for continuous data access.

Ultrahuman (via its M1 platform) targets performance purists by building a closed-loop athletic tracking system. Pairing Abbott FreeStyle Libre sensors with its proprietary recovery ecosystem—including the Ultrahuman Ring—the software generates a real-time "Metabolic Vector," factoring in HRV, resting heart rate, and temperature alongside glucose curves. Ultrahuman packages sensors in subscription or multi-pack tiers, roughly costing $240 to $299 for a one-month supply, and appeals particularly to triathletes and ultra-endurance runners who want unified recovery and fueling metrics in one interface.

Intra-Race Fueling Strategies and Carbohydrate Absorption Windows

In endurance athletics lasting longer than 90 minutes, maintaining blood glucose via exogenous carbohydrate feeding is essential for sparing liver glycogen and sustaining maximal mitochondrial ATP turnover. Current sports nutrition guidelines suggest an intake rate of 30 to 60 grams of carbohydrate per hour for events under two hours, scaling up to 90 to 120 grams per hour for multi-hour ultra-events when using mixed-source formulations (such as 1:0.8 or 2:1 maltodextrin-to-fructose ratios that leverage both SGLT1 and GLUT5 intestinal transporters).

CGMs offer value not by dictating instant fueling decisions during sprints, but by identifying prolonged glycemic downtrends before symptomatic hypoglycemia occurs. In resting conditions, non-diabetic glucose maintains a tightly regulated band between 70 and 99 mg/dL. During heavy endurance bouts, reading a continuous slope toward 65–70 mg/dL provides an early warning that current gastric emptying or intake rates are failing to match carbohydrate combustion rates. Conversely, athletes can use post-session CGM logs to identify reactive hypoglycemia—a drop in circulating glucose occurring when high-glycemic carbohydrates are consumed within 45 minutes of starting a workout, prompting an unhelpful insulin surge just as exercise-induced GLUT4 translocation peaks.

Nocturnal Glucose Stability, Sleep Quality, and Autonomic Recovery

The most clinically actionable data a CGM provides for athletes often occurs off the racecourse, particularly during sleep. Overnight glucose stability is a sensitive proxy for sympathetic tone, liver glycogen repletion, and systemic systemic stress. In a fully recovered state, baseline overnight glucose typically forms a stable horizontal line between 75 and 90 mg/dL.

Significant nocturnal glucose instability—characterized by jagged spikes or a persistent drift above 105 mg/dL—frequently points to autonomic imbalance, incomplete glycogen restoration, or nocturnal cortisol secretion. In athletes undergoing heavy training blocks, late-night high-fat or high-protein meals can slow gastric clearance and sustain elevated glucose via delayed gluconeogenesis, disrupting deep sleep architecture.

Systemic oxygenation also directly modulates nocturnal glycemic stability. Sleep-disordered breathing, including upper airway resistance and obstructive sleep apnea, triggers intermittent nocturnal hypoxemia and sympathetic micro-arousals. These events stimulate systemic catecholamine release and acute hepatic glucose dumping throughout the night. Athletes managing persistent nocturnal desaturations, chronic morning fatigue, and unexplainable overnight glucose spikes may benefit from diagnostic sleep evaluations, where interventions such as CPAP machines have been shown to stabilize nocturnal autonomic tone and restore normal baseline glucose regulation.

Frequently Asked Questions

Q: Can a CGM replace traditional fingerstick lactate and glucose testing during training?

No. CGMs measure interstitial glucose on a 5- to 15-minute physiological delay, meaning they cannot capture the instantaneous shifts required for precise lactate threshold mapping or acute trackside calibration. Capillary fingersticks remain the gold standard for immediate, highly accurate athletic measurements.

Q: Why does my glucose spike above 170 mg/dL during high-intensity intervals without eating?

Intense exercise triggers an endogenous surge of epinephrine and cortisol, which signals the liver to rapidly break down glycogen into free glucose via glycogenolysis. This is a normal, non-pathological evolutionary response that ensures contracting muscles have immediate access to metabolic substrate.

Q: Are CGM sensors prone to compression artifacts during sleep?

Yes. If you sleep directly on top of the sensor, physical pressure compresses the capillary bed and interstitial fluid surrounding the filament. This leads to a false, precipitous drop in reported glucose—often triggering low-glucose alerts—that quickly resolves once mechanical pressure is removed.

Q: Do athletes need to wear a CGM year-round to derive performance benefits?

Current consensus among sports dietitians suggests that continuous year-round wear is rarely necessary for non-diabetic athletes. Intermittent use—such as a 4-to-6-week block during peak training—is typically sufficient to dial in baseline nutrition, identify gut tolerances, and calibrate race-day fueling plans without fostering data fatigue or hyper-fixation.

References & Credits

This analysis draws upon established principles in exercise physiology, sports nutrition guidelines from the American College of Sports Medicine, and manufacturer specifications for commercial continuous glucose monitoring systems. Medical writing, technical editing, and physiological reviews were provided by clinical respiratory care and metabolic health specialists. This content is intended strictly for educational and informational purposes and does not constitute individual medical diagnosis, treatment, or clinical nutrition advice.

---

Take Your Home Health Further

Support every wellness protocol with clinical-grade monitoring and respiratory care. Explore our portable oxygen concentrators, CPAP machines, home pulse oximeters, and BiPAP therapy systems — or speak with a respiratory equipment specialist at (877) 699-4365 for a free consult. Prescription required for regulated equipment.